Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GREGG;, I.
Right arrow Articles by THIADENS, H A
Right arrow Search for Related Content
PubMed
Right arrow Articles by GREGG;, I.
Right arrow Articles by THIADENS, H A
Thorax 2000;55:807 ( September )

Letters to the editor

PEF versus FEV1
Reply to letter

PEF versus FEV1

The first 150 words of the full text of this article appear below.

The assertion by Dr Thiadens and colleagues1 that identification of airflow limitation and estimation of its reversibility by a bronchodilator is less reliable when measured by peak expiratory flow (PEF) than by forced expiratory volume in one second (FEV1) cannot be allowed to go unchallenged. They measured both values with a Microlab 3300 turbine spirometer, disregarding the fact that, in primary care, PEF is almost always measured by peak flow meters of variable orifice type which employ an entirely different principle and give considerably higher values. Jones and Mullee,2 who compared a similar Microlab turbine spirometer with a mini-Wright meter, found that values of PEF measured by the latter were, on average, 87 l/min higher. Hence, the values reported by Thiadens et al would have been much higher if they had been measured with a peak flow meter.

To compare the reliability of PEF and FEV1 for estimating magnitude of airflow . . . [Full text of this article]




This article has been cited by other articles:


Home page
Biol Res NursHome page
C. McCarley, S. K. Hanneman, N. Padhye, and M. H. Smolensky
A pilot home study of temporal variations of symptoms in chronic obstructive lung disease.
Biol Res Nurs, July 1, 2007; 9(1): 8 - 20.
[Abstract] [PDF]


Home page
ThoraxHome page
C G Elliott and H I Palevsky
Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis
Thorax, June 1, 2004; 59(6): 536 - 537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & British Thoracic Society